Answers are grounded in this paper and cite their sources.
Analysis showed zuranolone-treated patients with PPD experienced greater symptom improvement than SSRI-treated patients from Day 15 onward, with largest mean difference at Day 45. Adjusting for differences between placebo arms, zuranolone may be associated with greater PPD symptom improvement (measured by EPDS) vs. SSRIs.
No takes yet. Share an insight, caveat, or question.
Meltzer‐Brody et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: